
⸺ Synova Research
Master endogenous antioxidant tripeptide studied for redox balance, detoxification pathways and cellular protection in preclinical models.
Secure checkout via UK open banking. Free shipping on orders over £100.
Independently tested
COA on request
Next-day UK dispatch
Order before midnight
Research use only
Not for human consumption
⸺ Important
⸺ Overview
Glutathione (GSH) is a naturally occurring tripeptide of glutamate, cysteine and glycine. Researchers study it for its central role in cellular redox balance, phase II detoxification, immune function and protection against oxidative stress.
⸺ Mechanism of Action
Glutathione donates electrons via its thiol group to neutralise reactive oxygen species and conjugates with xenobiotics through glutathione-S-transferases. In animal models, supplementation supports hepatic detoxification, antioxidant capacity and mitochondrial protection.
⸺ Research
Animal studies show elevated tissue GSH levels following supplementation, with reduced oxidative-stress markers.
Preclinical work has examined GSH's role in supporting liver detox enzymes and protecting against chemical injury.
Research has explored GSH's influence on melanin synthesis pathways in dermatological models.
Summarised from preclinical literature for informational purposes only. Not medical or veterinary advice. Synova Research products are sold strictly for in-vitro and laboratory research.
⸺ Details

Investigational triple receptor agonist targeting GLP-1, GIP and glucagon — studied in animal models for appetite control, energy expenditure and glucose balance.

Dual GLP-1 and GIP receptor agonist studied in preclinical models for glucose regulation, insulin sensitivity and energy balance.

Synthetic analogue of the GLP-1 hormone used in research to study glucose regulation, insulin secretion and the incretin response.